Results 251 to 260 of about 78,948 (301)

Feline Alimentary Lymphomas: Established Concepts and an Underexplored Molecular Landscape. [PDF]

Curr Issues Mol Biol
Szafron LA, Parys M, Parys M, Szafron LM.   +3 more
europepmc   +1 more source

OCTN2 Activates a Non‐Canonical Carnitine Metabolic Pathway to Promote MASH‐HCC Progression and Immunotherapy Resistance

Advanced Science, Volume 13, Issue 16, 18 March 2026.
In non‐MASH‐HCC, L‐carnitine promotes tumor progression primarily through its classical role in enhancing fatty acid oxidation (FAO). However, in MASH‐HCC, where FAO is markedly suppressed, L‐carnitine shifts from this canonical function to serve instead as an intracellular acetyl group buffer.
Chuqi Xia, Xiao Zhang, Jinze Li, Ning Xu, Sheng Hu, Qiyu Lu, Yuxuan Li, Taifu Xiao, Xu Li, Xue Wang, Kequan Xu, Daoming Liang   +11 more
wiley   +1 more source

Immunological aspects of halo nevus (Sutton's Nevus). [PDF]

Front Immunol
Hlača N, Vičić M, Prpić-Massari L.
europepmc   +1 more source

Development and evaluation of an inhalable nanoemulsion system for enhancing NK cell function against osteosarcoma pulmonary metastases. [PDF]

Front Immunol
Hwang S, Bates PD, Valkanioti V, Chang CC, Mecozzi S, Capitini CM.   +5 more
europepmc   +1 more source

Gut microbial metabolite butyrate boosts p53-expressing telomerase-specific oncolytic adenovirus efficacy by enhancing infectivity and activating MHC-I/cGAS-STING. [PDF]

Cancer Immunol Immunother
Sakamoto M, Kuroda S, Katayama T, Mikane Y, Hanzawa S, Kadowaki D, Yoshida Y, Hamada Y, Sugimoto R, Yagi C, Hashimoto M, Kanaya N, Kakiuchi Y, Kikuchi S, Shigeyasu K, Tazawa H, Kagawa S, Urata Y, Fujiwara T.   +18 more
europepmc   +1 more source

Histopathological Characterization and Differential Expression of miRNAs in Male Pediatric Patients With Lichen Sclerosus. [PDF]

Andrology
Flammang V, Hartmann A, Stöhr R, Weigelt K, Geppert C, Stuebs FA, Beckmann MW, Wullich B, Taubert H, Marcou M, Wach S.   +10 more
europepmc   +1 more source

TGF-β-driven NK Cells plasticity in hepatocellular carcinoma. [PDF]

Front Immunol
Reverberi V, Montali A, Vecchi A, Rossi M, Pelagatti A, Doselli S, Farina B, Olivani A, Economopoulos G, Dalla Valle R, Laccabue D, Ferraglia F, Penna A, Fisicaro P, Boni C, Missale G.   +15 more
europepmc   +1 more source

Granzyme A activates another way to die [PDF]

Immunological Reviews, 2010
Summary:  Granzyme A (GzmA) is the most abundant serine protease in killer cell cytotoxic granules. GzmA activates a novel programed cell death pathway that begins in the mitochondrion, where cleavage of NDUFS3 in electron transport complex I disrupts mitochondrial metabolism and generates reactive oxygen species (ROS).
Judy Lieberman
exaly   +3 more sources